Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up

Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up

Aims: Ivacaftor is a revolutionary treatment option for cystic fibrosis (CF) patients with G551D and other gating mutations. The aim of this study was to evaluate the clinical status of patients on ivacaftor who were followed for up to 6 years together with an evaluation of ivacaftor therapy in one...

Full description

Bibliographic Details
Main Authors: Libor Fila, Lucie Valentova Bartakova, Alzbeta Grandcourtova, Miloslav Marel, Radovan Drnek, Alena Bilkova, Milan Macek, Pavel Drevinek
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-06-01
Series:Biomedical Papers
Subjects:
cystic fibrosis
adults
lung disease
ivacaftor
Online Access:https://biomed.papers.upol.cz/artkey/bio-201602-0015_Ivacaftor_in_cystic_fibrosis_adults_Czech_experience_with_six_years_of_follow-up.php

Similar Items

Similar Items